1 min read
LeonaBio Posts $0.89 Q3 GAAP Loss Per Share, Missing Estimates by 20 Cents
Cash, cash equivalents and investments totaled $32.3 million at Sept. 30, down from $88.3 million at year-end 2025.

LeonaBio, Inc. (LONA) posted a third-quarter GAAP loss of $0.89 per share, 20 cents worse than estimates, as cash and investments fell and quarterly operating cash use increased.
Cash, cash equivalents and investments totaled $32.3 million as of Sept. 30, 2026, down from $88.3 million at the end of 2025.
Net cash used in operations was $18.98 million in the quarter ended Sept. 30, compared with $4.7 million in the same quarter of 2025.